Search Results - "Vallefuoco, L"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    The cobas P 630 instrument: A dedicated pre-analytic solution to optimize COBAS® AmpliPrep/COBAS® TaqMan® system workflow and turn-around-time by Vallefuoco, L., Sorrentino, R., Spalletti Cernia, D., Colucci, G., Portella, G.

    Published in Journal of virological methods (01-12-2012)
    “…The cobas p 630, a fully automated pre-analytical instrument for primary tube handling recently introduced to complete the Cobas® TaqMan systems portfolio, was…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays by Veropalumbo, E, Marrone, A, Vallefuoco, L, Perruolo, G, Orlando, R, Scordino, F, Tosone, G, Zampino, R, Trani, B, Genovese, A, Spadaro, G, D'Orio, C, Portella, G

    Published in Intervirology (01-01-2010)
    “…Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B virus (HBV) infection. Mutations of the s gene involving…”
    Get more information
    Journal Article
  4. 4
  5. 5

    The cobas P 630 instrument: A dedicated pre-analytic solution to optimize COBAS registered AmpliPrep/COBAS registered TaqMan registered system workflow and turn-around-time by Vallefuoco, L, Sorrentino, R, Spalletti Cernia, D, Colucci, G, Portella, G

    Published in Journal of virological methods (01-12-2012)
    “…The cobas p 630, a fully automated pre-analytical instrument for primary tube handling recently introduced to complete the Cobas registered TaqMan systems…”
    Get full text
    Journal Article
  6. 6

    JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level by Lanzillo, Roberta, Liuzzi, Raffaele, Vallefuoco, Luca, Moccia, Marcello, Amato, Luca, Vacca, Giovanni, Vacchiano, Veria, Portella, Giuseppe, Brescia Morra, Vincenzo

    Published in Therapeutics and clinical risk management (01-01-2014)
    “…Natalizumab-treated patients have a higher risk of developing progressive multifocal leukoencephalopathy. Exposure to John Cunningham virus (JCV) is a…”
    Get full text
    Journal Article
  7. 7

    Expression of GM-CSF receptor and “in vitro” effects of GM-CSF on human fibroblasts by Postiglione, Loredana, Montagnani, Stefania, Riccio, Antonio, Ladogana, Paolo, Salzano, Salvatore, Vallefuoco, Luca, Rossi, Guido

    Published in Life sciences (1973) (01-06-1998)
    “…In the present study the effects of Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) on fibroblast growth and activity have been studied. In this…”
    Get full text
    Journal Article
  8. 8